IHAM
IDYA icon

Integral Health Asset Management’s IDEAYA Biosciences IDYA Stock Holding History

Integral Health Asset Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.73M Buy
+100,000
New +$3.06M 0.15% 80

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Integral Health Asset Management's IDYA Position: Q2 2026 in Review

Integral Health Asset Management opened a new position in IDEAYA Biosciences (IDYA) in Q2 2026: 100,000 shares worth $3.73M. The stake represents 0.15% of the portfolio and ranks #80 among its holdings.

282 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Integral Health Asset Management held 100,000 shares of IDEAYA Biosciences worth $3.73M as of Q2 2026.
  • IDEAYA Biosciences was a new Integral Health Asset Management position in Q2 2026.
  • IDEAYA Biosciences made up 0.15% of Integral Health Asset Management's portfolio in Q2 2026, its #80 holding.
  • 282 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.